Zavzpret is the first nasal spray approved to block calcitonin gene-related peptide, a protein believed to contribute to migraines.
The Food and Drug Administration approved Pfizer's Zavzpret this week. Pfizer says it's the first nasal spray approved to block calcitonin gene-related peptide, a protein believed to contribute to migraines.
In a clinical study, people experienced pain relief as soon as 15 minutes after using the medication. "As a nasal spray with rapid drug absorption, Zavzpret offers an alternative treatment option for people who need pain relief or cannot take oral medications due to nausea or vomiting, so they can get back to normal function quickly," said Dr. Kathleen Mullin, associate medical director at New England Institute for Neurology & Headache.Migraines can last up to 72 hours if untreated, according to the National Institutes of Health.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Pfizer says the FDA has approved its migraine nasal spray ZavzpretDrugmaker plans to roll out the drug, which it says can relieve migraine symptoms in 30 minutes, to pharmacies in July.
Weiterlesen »
FDA approves Pfizer's new nasal spray treatment for migrainesThe FDA approved Pfizer's newest drug on the migraine market, Zavzpret (zavegepant), the first and only migraine treatment offered in a nasal spray.
Weiterlesen »
FDA Approves Amphastar Pharma's Nasal Spray for Opioid OverdoseAmphastar Pharmaceuticals Inc said on Wednesday the FDA had approved its nasal spray for emergency treatment of known or suspected opioid overdose.
Weiterlesen »
Pfizer wins FDA approval for its migraine nasal sprayPfizer Inc. said Friday the U.S. Food and Drug Administration has approved its migraine nasal spray Zavzpret. The treatment is the first and only calcitonin...
Weiterlesen »
US FDA approves Pfizer's pain-relief nasal spray for migraineThe U.S. Food and Drug Administration on Friday approved Pfizer Inc's nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches.
Weiterlesen »
FDA approves nasal spray for migraines that may relieve symptoms within 30 minutesTh FDA approved Zavegepant, sold under the brand name Zavzpret, after studies showed it more effective than a placebo at treating migraine symptoms within 30 minutes and up to 48 hours later. FDA approves migraine nasal spray that works in minutes
Weiterlesen »